S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Abou-Alfa
    Abou-Alfa
  5. Chaganti
    Chaganti
  6. Lin
    Lin
  7. Janjigian
    Janjigian
  8. Jhanwar
    Jhanwar
  9. Tang
    Tang
  10. Clarkson
    Clarkson

Groups

  1. Department of Medicine (280)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)
  7. Sloan Kettering Institute Postdocs (55)
  8. Surgery (54)
  9. Thoracic Oncology (45)
  10. Department of Pathology and Laboratory Medicine (43)
Search Within
Formats
  1. Meeting Abstract (332)
  2. Journal Article (255)
  3. Book Section (20)
  4. Review (16)
  5. Conference Paper (10)
  6. Book Whole (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (280)
  2. Solid Tumor Oncology Division (160)
  3. Hematologic Malignancies, Division of (107)
  4. Center for Hematologic Malignancies (103)
  5. Survivorship Research (59)
  6. Gastrointestinal Oncology Service (57)

More Groups

People
  1. Lisa Bodei (32)
  2. Alexander Drilon (23)
  3. Robert Motzer (23)
  4. Ghassan Abou-Alfa (18)
  5. Steven Hajdu (18)
  6. Oscar Lin (16)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (37)
  4. 2022 (42)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Oncology Research and Treatment (226)
  2. Cytogenetics and Cell Genetics (61)
  3. Acta Cytologica (58)
  4. Neuroendocrinology (51)
  5. Acta Haematologica (32)
  6. Onkologie (19)

More Publications

Results (635)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting response to PRRT: Development and validation of a blood-based predictive biomarker
    Meeting Abstract

    Bodei, L.; Kidd, M.; Van der Zwan, W.; Singh, A.; Severi, S.; Drozdov, I.; Cwikla, J.; Baum, R. P.; Paganelli, G.; Kwekkeboom, D.; more...
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • PRRT in hindgut and cancer of unknown primary NEN
    Meeting Abstract

    Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Cichocki, A.; Roszkowska-Purska, K.; Dobkowski, P.; Bodei, L.; Cwikla, J.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Value of somatostatin receptor scintigraphy (SRS) in patients with appendiceal neuroendocrine neoplasms (ANEN) based on clinical follow-up and results of NETest
    Meeting Abstract

    Konsek, S.; Kolasinska-Cwikla, A.; Lewczuk-Myslinska, A.; Kidd, M.; Buscombe, J. R.; Bodei, L.; Cichocki, A.; Cwikla, J.; Modlin, I.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematological response
    Meeting Abstract

    Gertz, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Merlini, G.; Schonland, S.; Walling, J.; Kinney, G. G.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • TRITON2: An international, multicentre, open-label phase 2 study of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD)
    Meeting Abstract

    Heidenreich, A.; Carl, S.; Feyerabend, S.; Gleissner, J.; Grullich, C.; Heinrich, B.; Merseburger, A.; Miller, K.; Stenzl, A.; Steuber, T.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Three-year efficacy and safety update from the phase III Checkmate 025 study of nivolumab (NIVO) v everolimus (EVE) in patients with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Sharma, P.; Tykodi, S. S.; Escudier, B.; Carducci, M.; Oudard, S.; Hammers, H. J.; George, S.; Gauna, D. C.; Alva, A. S.; Richardet, M. E.; more...
    Oncology Research and Treatment (2018)

    Fulltext@MSK | Save
  • Assessment of the clinical utility of the NETest in a US registry-based study
    Meeting Abstract

    Liu, E.; Paulson, S.; Gulati, A.; Freudman, J.; Grosh, W.; Kafer, S.; Wickremesinghe, P.; Salem, R.; Bodei, L.
    Neuroendocrinology (2018)

    Fulltext@MSK | Save
  • Survival analysis after i.a. 90Y-DOTATATE PRRT, in patients with non-resectable, advanced, progressive, liver-dominant neuroendocrine neoplasms
    Meeting Abstract

    Nowicki, M. L.; Kolasińska-Ćwikła, A.; Lewczuk, A.; Sankowski, A.; Bodei, L.; Buscombe, J. R.; Kidd, M.; Modlin, I.; Ćwikła, J.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Lanreotide autogel/depot (LAN) in combination with peptide receptor radionuclide therapy (PRRT) in progressive digestive and lung neuroendocrine tumours (NETs): Design of the PRELUDE study
    Meeting Abstract

    Prasad, V.; Thanh, X. M. T.; Houchard, A.; Bodei, L.
    Neuroendocrinology (2017)

    Fulltext@MSK | Save
  • Resection of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas: A Nordic multicenter study
    Meeting Abstract

    Galleberg, R. B.; Knigge, U.; Janson, E. T.; Vestermark, L. W.; Haugvik, S. P.; Ladekarl, M.; Langer, S. W.; Grønbæk, H.; Österlund, P.; Hjortland, G.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save